Current Edition

Catalent

Catalent’s FDA write-up spurred Novo Nordisk’s Wegovy supply woes

Catalent received an FDA write-up for its syringe filling facility in Belgium, BioProcess International reports, adding that it is “allegedly” the culprit behind supply challenges for …

Continue Reading →